Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Hemodynamics Effect of Levcromakalim After Glibenclamide Administration Assessed by High Resolution MRA Technique in a Randomized, Double-blind, Cross-over and Placebo-controlled Study With Healthy Volunteers.

NCT03886922 is registered in ClinicalTrials.gov with Danish Headache Center as lead sponsor.

NCT NCT03886922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03886922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Hemodynamics Effect of Levcromakalim After Glibenclamide Administration Assessed by High Resolution MRA Technique in a Randomized, Double-blind, Cross-over and Placebo-controlled Study With Healthy Volunteers.
Lead sponsor
Danish Headache Center
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2019
Completion date
August 30, 2023
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral blood flow, headache, hemodynamics of cranial arteries